A potential synbiotic product improves the lipid profile of diabetic rats

Lipids in Health and Disease

Elizeu A Rossi¹  Regina C Vendramini²  Roseli A Pinto¹  Larissa S Celiberto¹  Daniela CU Cavallini¹  Nadiége D Pauly-Silveira¹  Mariana N Roselino¹ 

[1] Department of Food & Nutrition, School of Pharmaceutical Sciences, Sao Paulo State University, Araraquara, SP, Brazil;Department of Clinical Analysis, School of Pharmaceutical Sciences, Sao Paulo State University, Araraquara, SP, Brazil

关键词: Lipid profile;    Blood glucose;    Diabetes mellitus;    Prebiotics;    Probiotics;    Fermented soy product;   

Others  :  1160211
DOI  :  10.1186/1476-511X-11-114

 received in 2012-07-05, accepted in 2012-09-05,  发布年份 2012

【 摘 要 】

Background

Previous studies showed that intake of yacon or some lactic acid bacteria was able to inhibit the development of diabetes mellitus, by reducing glucose and associated symptoms, for example, the lipid profile.

Objective

The purpose of this study was to assess the consumption influence of a potential symbiotic product of soybean and yacon extract and fermented Enterococcus faecium CRL 183 and Lactobacillus helveticus ssp jugurti 416 in reducing blood glucose and lipid levels in an animal model.

Methods

Diabetes mellitus was chemically induced by intraperitoneal administration of streptozotocin (50 mg/kg body weight). The rats were divided into four groups (n=10): GI – non-diabetic animals that received only a standard chow diet (negative control), GII – diabetic animals that received only chow diet (positive control), GIII – diabetic animals that received the chow diet + 1 mL/kg body weight/day of soybean and yacon unfermented product, GIV – diabetic rats that received the chow diet + 1 mL/kg body weight/day of soybean and yacon fermented product. There was a seven-week treatment period and the following parameters were evaluated: animal body weight, food and water intake, blood glucose, enzyme activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), triglycerides levels, total cholesterol, HDL-C, non-HDL-C. Cell viability of the fermented product was checked weekly for a seven-week period.

Results

The product average viable population was 10⁸-10⁹ CFU/mL, by ensuring both the rods and cocci regular intake. No difference was observed between the water and feed intake and body weight of groups that received unfermented and fermented products and the untreated diabetic group. The same was observed for the blood glucose and AST and ALT activities, while some improvement was observed for a lipid profile, represented by reduction of triglycerides level by 15.07% and 33.50% in groups III and IV, respectively, and an increase of 23.70% in HDL-C level for group IV.

Conclusion

The results showed that the ingestion of a potential symbiotic product was neither able to promote improvement in some of the disease symptoms, nor reduce blood glucose. However, a positive effect on triglycerides levels and HDL-cholesterol was observed in the groups that received the unfermented product containing yacon extract and the fermented product with Enterococcus faecium CRL 183, as well as Lactobacillus helveticus ssp jugurti 416 and yacon extract (symbiotic product).

【 授权许可】

   
2012 Roselino et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Bransome ED: Financing the care of diabetes mellitus in the U.S. Diabetes Care 1992, 15:1-5.
• [2]Negri G: Diabetes melito: plantas e princípios ativos naturais hipoglicemiantes. Revista Brasileira de Ciências Farmacêuticas 2005, 41(2):121-142.
• [3]Robbins SL, Cotran RS, Kumar V, Taranto G: Patologia estrutural e funcional. 4th edition. Rio de Janeiro: Guanabara Kogan; 1991:817-826.
• [4]Shoelson SE: Insulin and other antidiabetic agents. In Kirk-Othmer encyclopedia of chemical technology. 3rd edition. New York: John Wiley; 1995:662-676.
• [5]Berne RM, Genuth SM: Fisiologia. 4th edition. Rio de Janeiro: Guanabara Koogan; 2000:190.
• [6]Godoy P: Pâncreas Endócrino. In Patologia. 6th edition. Edited by Bogliolo L. Rio de Janeiro: Guanabara Koogan; 2000:1004-1008.
• [7]Said O, Khalil K, Fulder S, Azaizeh H: Ethnopharmacological survey of medicinal herbs in Israel, the Golan heights and the West Bank Region. J Ethnopharmacol 2002, 3:251-265.
• [8]Mori DM, Baviera AM, De Oliveira RLT, Vendramini RC, Brunetti IL, Pepato MT: Temporal response pattern of biochemical analytes in experimental diabetes. Biotechnol Appl Biochem 2003, 38:183-191.
• [9]Ludke MC, López J: Colesterol e composição dos ácidos graxos nas dietas para humanos e na carcaça suínas. Ciência Rural 1999, 29(1):181-187.
• [10]Armaganijan D, Batlouni M: Impacto f traditional risk factors. In Revista da sociedade de cardiologia do Estado de São Paulo. 10th edition. São Paulo: Edson Stefanini, SOCESP; 2000:689-693.
• [11]Rifai N, Warnick GR: Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In Tietz textbook of clinical chemistry and molecular diagnostics. 40th edition. Edited by Burtis CA, Ashwood ER, Bruns DE. St. Louis: Elsevier Saunders; 2006:903-981.
• [12]FAO/WHO: Evaluation of health and nutritional properties in food including powder milk with live lactic acid bacteria. In Expert consultation report. Cordoba; 2011. http://www.fao.org/es/ESN/Probio/probio.htm webcite
• [13]Rossi ER: Desenvolvimento e avaliação biológica do potencial hipocolesterolêmico de um novo produto probiótico de soja. In Tese (livre docência)-faculdade de ciências farmacêuticas. Araraquara: Universidade Estadual Paulista; 2000.
• [14]Rossi EA, Vendramini RC, Carlos IZ, Ueiji IS, Squinzari MM, Silva Junior SI, Valdez GF: Effects of a novel soy product on the serum lipids of hypercholesterolemic rabbits. Arq Bras Cardiol 2000, 74:213-216.
• [15]Rossi EA, Vendramini RC, Carlos IZ, Oliveira MG, Valdez GF: Efeito de um novo produto fermentado de soja sobre os lípides séricos de homens adultos normocolesterolêmicos. Arq Latin Nutr 2003, 53:47-51.
• [16]Rossi EA, Rosier I, Dâmaso AR, Carlos IZ, Vendramini RC, Abdalla DSP, Talarico VH, Minto DF: Determinação de isoflavonas nas diversas etapas do processamento de “iogurte” de soja. Alim Nutr 2004, 15(2):93-99.
• [17]Manzoni MSJ, Rossi EA, Carlos IZ, Vendramini RC, Duarte ACGO, Tenorio NM, Amorim DB, Damaso AR: Fermented soy product supplemented with isoflavones affects adipose tissue in a regional-speccific manner and improves HDLcholesterol in rats fed on a cholesterol-enriched diet. Eur Food Res Technol 2008, 227(6):1591-1597.
• [18]Rivera D, Manrique : Zumo de yacón - ficha técnica. In Centro internacional de la Papa (CIP). Lima: Disponível em; 2005. http://www.cipotato.org/artc/cipcrops/fichazumoyacon.pdf webcite
• [19]Aybar MJ, Sánchez Riera AN, Grau A, Sánchez SS: Hipoglycemic effect of the water extract of smallantus sonchifolius (yacon) leaves in normal and diabetic rats. J Ethnopharmacol 2001, 74(2):125-132.
• [20]Pereira D, Gibson GR: Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Critical Rev Biochem Molec Biol 2002, 37(4):259-281.
• [21]Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T: Antidiabetic effects of an oral administration of lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr J 1997, 44:357-365.
• [22]Matsuzaki T, Nagata Y, Kado S, Uchida K, Hashimoto S, Yokokura T: Effect of oral administration of lactobacillus casei on alloxan-induced diabetes in mice. APMIS 1997, 105:637-642.
• [23]Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M, Hosono A: Antidiabetic effect of lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 2003, 67:1421-1424.
• [24]Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM: Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
• [25]Yadav H, Jain S, Sinha PR: Antidiabetic effect of probiotic dahi containing lactobacillus acidophilus ans lactobacillus casei in high fructose fed rats. Nutr 2007, 23:62-68.
• [26]Yun SI, Park HO, Kang JH: Effect of lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 2009, 107(5):1681-1686.
• [27]Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT: The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin and phytoestrogens. Int J Mol Sci 2009, 10:3755-3775.
• [28]Vendramini AP: Efeito da ingestão de um produto de soja fermentado com enterococcus faecium e lactobacillus helveticus. In Dissertação (mestrado em análises clínicas)-faculdade de ciências farmacêuticas. Araraquara: Universidade Estadual Paulista; 2002.
• [29]Bedani R, Rossi EA, Lepera JS, Wang CC, Valdez GF: Efeito de um novo produto fermentado de soja, enriquecido com isoflavonas e cálcio, sobre o tecido ósseo de ratas. Arc Latinoam Nutr 2006, 56:146-152.
• [30]Shiguemoto GE, Rossi EA, Baldissera V, Gouveia CH, Valdez GMF, Perez SEA: Isoflavone-supplemented soy yoghurt associated with resistive physical exercise increase bone mineral density of ovariectomized rats. Maturitas 2007, 57:261-270.
• [31]Rossi EA, Cavallini DCU, Carlos IZ, Vendramini RC, Dâmaso AR, Valdez GF: Intake of isoflavone-supplemented soy yogurt fermented with enterococcus faecium lowers serum total cholesterol and non-HDL cholesterol of hypercholesterolemic rats. Eur Food Res Technol 2008, 228(2):275-282.
• [32]Cavallini DCU: Efeito do “iogurte” de soja fermentado com E. faecium e suplementado com isoflavonas nos marcadores laboratoriais de risco cardiovascular e na aterosclerose. In 140f. relatório (pós-doutorado) – faculdade de ciências farmacêuticas. Araraquara: UNESP; 2009.
• [33]Pauly-Silveira ND: O emprego da metodologia de resposta no desenvolvimento de um novo produto simbiótico, fermentado com enterococcus faecium CRL 183 e lactobacillus helveticus ssp jugurti 416, à base de extratos aquosos de soja e de yacon (smallanthus sonchifolius). In UNESP, dissertação (mestrado em alimentos e nutrição - área de ciência dos alimentos) - faculdade de ciências farmacêuticas. Araraquara - SP: Universidade Estadual Paulista; 2009.
• [34]Yoruk M, Kanter M, Meral I, Agaoglu Z: Localization of glycogen in the placenta and fetal and maternal livers of cadmium exposed diabetic pregnant rats. Biol Trace Elem Res 2004, 96:217-226.
• [35]Kanter M, Yoruk M, Koc A, Meral I, Karaca T: Effects of cadmium exposure on morphological aspects of pancreas, weights of fetus and placenta in streptozotocin-induced diabetic pregnant rats. Biol Trace Elem Res 2003, 93:189-200.
• [36]Muir JG, Shepherd SJ, Rosella O, Rose R, Barrett JS, Gibson PR: Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem 2007, 55(16):6619-6627.
• [37]Lerco MM, Spadella CT, Machado JLM, Schellini SA, Padovani CR: Experimental alloxan diabetes induced: a model for clinical and laboratory studies in rats. Acta Cir Bras 2003, 18(2):132-142. [online]
• [38]Trinder R: Determination of glucose in blood using glucose with alternative oxygen acceptor. Ann Clin Biochem 1969, 6:27-27.
• [39]Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, Mcdonald JM, Parrot M: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002, 48:436-472.
• [40]Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, Robbins DC, Howard BV: Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care 2003, 26(1):16-23.
• [41]Desjardins ML, Roy D, Goulet J: Growth of bifidobacteria and their enzyme profiles. J Dairy Sci 1990, 73:299-307.
• [42]ADA (American Dietetic Association): Position of the American dietetic association: functional foods. J Am Diet Assoc 1999, 99:1278-1285.
• [43]Quinteros ETT: Produção com tratamento enzimático e avaliação do suco de yacon. In Tese (doutorado em tecnologia de alimentos) – faculdade de engenharia de alimentos. Campinas: Universidade Estadual de Campinas; 2000.
• [44]Genta SB, Cabrera WM, Mercado MI, Grau A, Catalán CA, Sánchez SS: Hypoglycemic activity of leaf organic extracts from smallanthus sonchifolius: constituents of the most active fractions. Chem Biol Interact 2010, 185(2):143-152.
• [45]Xiang Z, He F, Kang TG, Dou DQ, Gai K, Shi YY, Kim YH, Dong F: Anti-diabetes constituents in leaves of smallanthus sonchifolius. Nat Prod Commun 2010, 5(1):95-98.
• [46]Wong KK, Tzeng ES: Appearance of different diabetic symptoms after streptozocin administration: a comparison study. Biochem Mol Biol Int 1993, 30:1035-1041.
• [47]Meigs JB, Hu FB, Rifai N, Manson JE: Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. J Am Med Assoc 2004, 291(16):1978-1986.
• [48]Passos LML, Park YK: Frutooligossacarídeos: implicações na saúde humana e utilização em alimentos. Ciência Rural 2003, 33(2):385-390.
• [49]Grover JK, Vats V, Rathi SS: Anti-hyperglycemic effect of eugenia jambolana and tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. J Ethnopharmacol 2000, 73(3):461-470.
• [50]Rakieten N, Rakieten L, Nadkarni M: Studies on the diabetogênico action of streptozotocin. Cancer Chemother Rep 1963, 29:91-98.
• [51]Maffezzoli AS: O efeito da insulina sobre concentrações glicêmicas e lipídicas em ratos normais e diabéticos induzidos pela estreptozotocina. In Trabalho de conclusão de curso. Santa Catarina: Universidade do Vale do Itajaí, UNIVALI; 2004.
• [52]Silva ADS: A raiz yacon (smallanthus sonchifolius poepping & endlicher) como fonte de fibras alimentares, sua caracterização físico-quimica, uso na panificação e sua influência na glicemia pós–prandial. In Tese (doutorado) - departamento de ciência e tecnologia de alimentos. Florianópolis: Universidade Federal de Santa Catarina; 2007.
• [53]Ali MM, Agha FG: Amelioration of streptozotocin-induced diabetes mellitus, oxidative stress and dyslipidemia in rats by tomato extract lycopene. Scand J Clin Lab Invest 2009, 69(3):371-379.
• [54]Baroni S, Kemmelmeier FS, Caparroz-Assef SM, Cuman RKN, Bersani-Amado CA: Effect of crude extracts of leaves of smallanthus sonchifolius (yacon) on glycemia in diabetic rats. Braz J Pharma Sci 2008, 44(3):521-530.
• [55]Kaur IP, Chopra K, Saini A: Probiotics: potential pharmaceutical applications. Eur J Pharma Sci 2002, 15:1-9.
• [56]Koop-Hoolihan L: Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 2001, 101:229-238.
• [57]Contreras F, Rivera M, Vásquez JF, YáneZ CJB, De La Parte MA, Velasco M: Diabetes e hipertensión aspectos clínicos y terapêuticos. Arch Vzlanos Farmacol Terap 2000, 19:9-24.
• [58]Rossi EA, Carlos IZ, Vendramini RC, Machado CO, Cyrillo RNS, Perazzo FF, Valdez GF: Avaliação do potencial alergênico de um novo produto fermentado de soja. RBCF Ver Brás Ciênc Farm São Paulo 2000, 21(1):103-113.
• [59]Pigeon RM, Cuesta EP, Gilliland SE: Binding of free bile acids by cells of yogurt starter culture bacteria. J Dairy Sci 2002, 85:2705-2710.
• [60]Liong MT, Shah NP: Acid and bile tolerance and the cholesterol removal ability of bifidobacteria strains. Biosci Micro 2005, 24:1-10.
• [61]Liong MT, Shah NP: Roles of probiotics and prebiotics on cholesterol: the hypothesized mechanisms. Nutrafoods 2005, 4:45-57.
• [62]Khamisy AESE: Effect of bifidobacterium and lactobacillus acidophilus in diabetic rats. In The 5th Arab and 2nd international: annual scientific conference. Egypt: Faculty Specific Education - Mansoura University; 2010:2425-2439.
• [63]Zhang F, Xiaomim H, Xiaobing F, Guije L, Hong Y: Selection and optimization procedure of symbiotic for cholesterol removal. Anaerobe 2007, 13:185-192.
• [64]Kiebling G, Schneider J, Jahreis G: Longterm consuption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr 2002, 56:843-849.
• [65]Greany KA, Bonorden MJ, Hamilton-Reeves JM, McMullen MH, Wangen KE, Phipps WR, Feirtag J, Thomas W, Kurzer MS: Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr 2008, 62:232-237.